Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

PY motifs of Rod1 are required for binding to Rsp5 and for drug resistance.

FEBS letters | Aug 14, 2002

http://www.ncbi.nlm.nih.gov/pubmed/12163175

In Saccharomyces cerevisiae, the overexpression of ROD1 confers resistance to o-dinitrobenzene (o-DNB), a representative of target drugs of glutathione S-transferase. The roles of Rod1 in drug resistance have remained to be determined. We isolated the rog3 mutation as a suppressor mutation of the temperature sensitivity of the strain, in that two of the total four glycogen synthase kinase 3 homologs were deleted. Rog3 is homologous to Rod1, and its overexpression also conferred resistance to o-DNB. Furthermore, these two proteins have PY-motifs, and bound to Rsp5, a hect-type ubiquitin ligase. The rsp5-101 mutant showed sensitivity to o-DNB as did the rod1 mutant, a mutant Rod1 containing altered PY motifs was defective in ability to bind to Rsp5 and in conferring o-DNB resistance. These results suggest that interaction of Rod1 and Rsp5 is important for drug resistance.

Pubmed ID: 12163175 RIS Download

Mesh terms: Amino Acid Motifs | Dinitrobenzenes | Drug Resistance, Multiple | Endosomal Sorting Complexes Required for Transport | Fungal Proteins | Membrane Proteins | Microbial Sensitivity Tests | Mutation | Precipitin Tests | Protein Binding | Saccharomyces cerevisiae | Saccharomyces cerevisiae Proteins | Temperature | Ubiquitin-Protein Ligase Complexes

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.